Clariane SE (EPA:CLARI)
France · Delayed Price · Currency is EUR | Market Cap | 1.42B -9.4% |
| Revenue (ttm) | 5.35B +0.8% |
| Net Income | 12.57M |
| EPS | 0.03 |
| Shares Out | 356.50M |
| PE Ratio | 119.30 |
| Forward PE | 20.36 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 151,872 |
| Open | 4.010 |
| Previous Close | 3.990 |
| Day's Range | 3.960 - 4.042 |
| 52-Week Range | 3.270 - 4.916 |
| Beta | 0.82 |
| Analysts | Buy |
| Price Target | 4.88 (+21.15%) |
| Earnings Date | Jul 29, 2026 |
About Clariane SE
Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care clinics, mental healthcare clinics, and medicine-surgery-obstetrics facilities. In addition, it offers medicalized nursing homes and alternative living... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for CLARI stock is "Buy." The 12-month stock price target is €4.88, which is an increase of 21.15% from the latest price.
News
Clariane SE Earnings Call Transcript: Q2 2026
Organic revenue grew 4.6% in H1 2026, with strong EBITDA margin expansion and significant deleveraging. Outlook targets sustained revenue and margin growth, supported by efficiency programs, AI adoption, and robust liquidity. Occupancy and pricing gains, especially in Germany and Benelux, remain key drivers.
Clariane SE Earnings release: Q2 2026
Clariane SE released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Clariane SE Quarterly report: Q2 2026
Clariane SE has published its Q2 2026 quarterly earnings report on July 30, 2026.
Clariane SE Slides: Q2 2026
Clariane SE has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
Clariane SE Earnings Call Transcript: Q1 2026
Solid organic revenue growth of +4.9% in Q1 2026 was driven by improved occupancy, pricing, and strong performance across all segments and geographies. Liquidity was strengthened by a successful EUR 500 million bond issue, and medium-term guidance was confirmed.
Clariane SE Earnings release: Q1 2026
Clariane SE released its Q1 2026 earnings on April 24, 2026, summarizing the period's financial results.
Clariane SE Slides: Q1 2026
Clariane SE has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 24, 2026.
Clariane SE Earnings Call Transcript: Q4 2025
Delivered strong 2025 results with 4.5% organic revenue growth, improved profitability, and reduced leverage. Strategic divestments, cost efficiency programs, and a robust outlook support continued margin and cash flow gains through 2028.
Clariane SE Annual report: Q4 2025
Clariane SE has published its Q4 2025 annual report on February 27, 2026.
Clariane SE Earnings release: Q4 2025
Clariane SE released its Q4 2025 earnings on February 27, 2026, summarizing the period's financial results.
Clariane SE Slides: Q4 2025
Clariane SE has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 27, 2026.
Clariane SE Earnings Call Transcript: Q3 2025
Revenue grew 4.9% organically in the first nine months of 2025, with Q3 acceleration and all segments contributing. EBITDA margin is set to reach ~12% in H2, supported by cost reduction and portfolio streamlining, while leverage and CapEx guidance remain unchanged.
Clariane SE Earnings release: Q3 2025
Clariane SE released its Q3 2025 earnings on October 28, 2025, summarizing the period's financial results.
Clariane SE Slides: Q3 2025
Clariane SE has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 28, 2025.